SGS completes expansion of bioanalytical testing laboratory in France

SGS is proud to announce that the expansion of its bioanalytical laboratory in Poitiers, France is complete, with the addition of a new 800 m2 building to meet growing global demand for bioanalytical testing services to support drug development

picture of

Breaking News

Navigo Proteins announces extension of partnership with ITM

Through the partnership, the company is developing targeted radiopharmaceutical candidates for the treatment of cancer

AI drug development specialist CytoReason enters the Japanese market

CytoReason and Summit Pharmaceuticals International have announced that CytoReason has entered the Japanese market with ...

ProBioGen gets green light for cell line tech research license

ProBioGen has announced the closing of a DirectedLuck Transposase Technology research license agreement with another ...

Accelerating drug discovery and design with electrons

Crystallography is the experimental science of determining the arrangement of atoms in crystalline solids. The research ...

BD glass syringes capable of storage at deep cold temperatures

An analysis of approximately 2000 syringes showed no negative impact on key product functions when stored at -20°C and ...

Almac and Queen’s University Belfast collaboration passes midpoint

The KTP project has achieved multiple successful outcomes including dissemination through peer-reviewed publication and ...

Manufacturing vaccines, digital twins and lessons learned: part I

Using a digital replica of the manufacturing process, the pharmaceutical industry is exploring the ability of virtual ...

Boehringer Ingelheim and OBT advance oncology candidate

The Boehringer Ingelheim drug candidate was discovered in a partnership with Oxford BioTherapeutics and enabled by ...

Hookipa announces clinical collaboration with Merck USA

The collaboration will evaluate the combination of Hookipa’s arenaviral immunotherapeutic, and Merck’s Keytruda as ...

Delivering fixed-dose combination therapies with hard capsules: part II

In this article, authors Dr Jnanadeva Bhat and Ms Anita Solanki describe how fixed-dose combination therapies can be ...

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Delivering fixed-dose combination therapies with hard capsules: part I

In this article, authors Dr Jnanadeva Bhat and Ms Anita Solanki describe how fixed-dose combination therapies can be ...

CytoSMART reopens research grant applications for Autumn

Through the grant, applicants can apply for either a Lux2, Lux3 FL, or an Omni live-cell imaging microscope, which they ...

CPI launches RNA Centre of Excellence

To prepare for global demand for the technology, CPI is expanding capacity at its site in Darlington to include GMP ...